HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Response to chlorpromazine treatment may be associated with polymorphisms of the DRD2 gene in Chinese schizophrenic patients.

Abstract
Previous studies have demonstrated that the -141C Ins/Del and TaqI A polymorphisms in the DRD2 gene affect the density of the dopamine D2 receptor. The present study examines the correlation between these two polymorphisms and the therapeutic response to chlorpromazine, a typical antipsychotic drug, in 135 inpatients with schizophrenia. Clinical symptoms were evaluated using the Brief Psychiatry Rating Scale (BPRS) before and after 8 weeks of treatment with 300-600 mg/day of chlorpromazine. Our results show that genotyping -141C Ins/Del may help to predict the efficacy of chlorpromazine treatment (P=0.01) due to the fact that patients with no Del allele showed greater improvement than those with Del allele on the overall BPRS (P=0.03), and that, therefore, the potential for therapy in patients with schizophrenia is related to the -141C Ins/Del polymorphism in the DRD2 gene. However, no such relationship was found for the TaqI A polymorphism.
AuthorsShengnan Wu, Qinghe Xing, Rui Gao, Xingwang Li, Niufan Gu, Guoyin Feng, Lin He
JournalNeuroscience letters (Neurosci Lett) Vol. 376 Issue 1 Pg. 1-4 (Mar 07 2005) ISSN: 0304-3940 [Print] Ireland
PMID15694263 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antipsychotic Agents
  • DRD4 protein, human
  • RNA, Messenger
  • Receptors, Dopamine D2
  • Receptors, Dopamine D4
  • Taq Polymerase
  • Chlorpromazine
Topics
  • Adult
  • Antipsychotic Agents (therapeutic use)
  • China (epidemiology)
  • Chlorpromazine (therapeutic use)
  • Female
  • Gene Deletion
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • Male
  • Polymorphism, Genetic
  • Psychiatric Status Rating Scales
  • RNA, Messenger (biosynthesis)
  • Receptors, Dopamine D2 (genetics)
  • Receptors, Dopamine D4
  • Reverse Transcriptase Polymerase Chain Reaction (methods)
  • Schizophrenia (drug therapy, genetics)
  • Taq Polymerase

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: